A phase I/II study to evaluate the safety, pharmacokinetics, and efficacy of PRJ1-3024 in patients with advanced solid tumors

被引：0
|
作者：
Zhang, Panpan
Qin, Yanru
Gong, Jifang
Wang, Yongsheng
Yang, Kunyu
Li, Yongsheng
Dai, Guanghai
Zhu, Ji
Sha, Sha
Tong, Ming
Liao, Xuebin
Shen, Lin
机构：
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China
[3] Beijing Canc Hosp, Dept Gastrooncol, Beijing, Peoples R China
[4] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[6] Chongqing Canc Hosp, Chongqing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[8] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[9] Zhuhai Yufan Biotechnol Co Ltd, Zhuhai, Guangdong, Peoples R China
[10] Tsinghua Univ, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2590
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics
    Nwankwo, Nwabundo
    Zhang, Zhe
    Wang, Ting
    Collins, Connie
    Resta, Lee
    Ermisch, Sabine
    Day, Jeannette
    Decker, Rodney
    Kornberg, Lori
    Nicol, Steven
    Thornton, Donald
    Armstrong, Deborah K.
    Carducci, Michael A.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 653 - 660
  • [42] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    William F. Maguire
    John C. Schmitz
    Jonas Scemama
    Ken Czambel
    Yan Lin
    Anthony G. Green
    Shaoyu Wu
    Huang Lin
    Shannon Puhalla
    John Rhee
    Ronald Stoller
    Hussein Tawbi
    James J. Lee
    John J. Wright
    Jan H. Beumer
    Edward Chu
    Leonard J. Appleman
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 643 - 654
  • [43] Safety, PK and preliminary efficacy of talazoparib in Japanese patients with advanced solid tumors; Phase 1 Study
    Naito, Yoichi
    Kuboki, Yasutoshi
    Ikeda, Masafumi
    Harano, Kenichi
    Matsubara, Nobuaki
    Toyoizumi, Shigeyuki
    Oishi, Masayo
    Hori, Natsuki
    Nagasawa, Takashi
    Kogawa, Takahiro
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
    Sunil Sharma
    Petronella O. Witteveen
    Martijn P. Lolkema
    Dagmar Hess
    Hans Gelderblom
    Syed A. Hussain
    Maria G. Porro
    Edward Waldron
    Sue-zette Valera
    Song Mu
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 87 - 95
  • [45] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
    Sharma, Sunil
    Witteveen, Petronella O.
    Lolkema, Martijn P.
    Hess, Dagmar
    Gelderblom, Hans
    Hussain, Syed A.
    Porro, Maria G.
    Waldron, Edward
    Valera, Sue-zette
    Mu, Song
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 87 - 95
  • [46] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
    Marije Slingerland
    Dagmar Hess
    Sally Clive
    Sunil Sharma
    Per Sandstrom
    Niklas Loman
    Maria G. Porro
    Song Mu
    Edward Waldron
    Sue-zette Valera
    Hans Gelderblom
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1089 - 1098
  • [47] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
    Slingerland, Marije
    Hess, Dagmar
    Clive, Sally
    Sharma, Sunil
    Sandstrom, Per
    Loman, Niklas
    Porro, Maria G.
    Mu, Song
    Waldron, Edward
    Valera, Sue-zette
    Gelderblom, Hans
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 1089 - 1098
  • [48] A phase I clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and antitumor activity of FN-1501 monotherapy in patients with advanced solid tumors.
    Richardson, Gary Edward
    Vaishampayan, Ulka N.
    Lin, Lin
    Bozon, Viviana
    Hui, Ai-Min
    Williamson, Stephen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
    Ghalib, Mohammad H.
    Pulla, Mariano Provencio
    Luken, Maria J. De Miguel
    de Juan, Virginia Calvo
    Chaudhary, Imran
    Hammami, M. Bakri
    Vikash, Sindhu
    Maitra, Radhashree
    Martinez, Sara
    Kahatt, Carmen
    Extremera, Sonia
    Fudio, Salvador
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 481 - 491
  • [50] Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study
    Ito, Yoshinori
    Suenaga, Mitsukuni
    Hatake, Kiyohiko
    Takahashi, Shunji
    Yokoyama, Masahiro
    Onozawa, Yusuke
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Hashigami, Kiyoshi
    Hasegawa, Hirotaka
    Takenaka, Nobuko
    Boku, Narikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (04) : 278 - 286
12345